
Lilly's New Drug Beats Ozempic in Diabetes Trial
Eli Lilly's experimental drug retatrutide outperformed the widely-used Ozempic in lowering blood sugar and reducing weight in a major diabetes study. The breakthrough offers new hope for millions managing type 2 diabetes.









%2Ffile%2Fattachments%2Forphans%2FFeatureimage24Aug_HaberdoedasPhotography_Pexelscopy_135558.jpg)
